Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...

Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...

How understanding readiness for change and embracing imperfections can help you break free from old habits, overcome ...

Dr. Ariz Sheikh - By following these strategies, you can better manage morning stiffness and improve your comfort and ...

Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...

Bristol-Myers Squibb (NYSE:BMY) on Saturday announced results from a late-stage trial for its psoriasis therapy Sotyktu in ...

Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...

Patients with hidradenitis suppurativa are at increased risk of developing several common inflammatory arthropathies in the years following diagnosis.

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...